Combined Topical Tranexamic Acid With Floseal® in Total Knee Arthroplasty
Comparison of Combined Topical Tranexamic Acid With Floseal® With Intravenous Tranexamic Acid on Blood Loss in Total Knee Arthroplasty
Sponsor: Chang Gung Memorial Hospital
Listed as NCT03328832, this PHASE4 trial focuses on Osteoarthritis, Knee and remains completed. Sponsored by Chang Gung Memorial Hospital, it has been updated 7 times since 2017, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Sep 2021 — Jul 2024 [monthly]
Completed PHASE4
Status: Unknown Status → Completed
-
Jan 2021 — Sep 2021 [monthly]
Unknown Status PHASE4
▶ Show 2 earlier versions
-
May 2019 — Jan 2021 [monthly]
Unknown Status PHASE4
Status: Not Yet Recruiting → Unknown Status
-
Nov 2017 — May 2019 [monthly]
Not Yet Recruiting PHASE4
First recorded
Sep 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Chang Gung Memorial Hospital
For direct contact, visit the study record on ClinicalTrials.gov .